• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Open Forum Infect Dis . Development and External Validation of a Prognostic Prediction Model for Hospitalization in SARS-CoV-2-Infected Ambulatory P

tetano

Editor, Senior Moderator
Open Forum Infect Dis


. 2026 Apr 16;13(5):ofag226.
doi: 10.1093/ofid/ofag226. eCollection 2026 May.
Development and External Validation of a Prognostic Prediction Model for Hospitalization in SARS-CoV-2-Infected Ambulatory Patients

Robert J Williams[SUP] 1 [/SUP], Ben J Brintz[SUP] 1 2 [/SUP], Nancy Grisel[SUP] 3 [/SUP], Josh V Otterloo[SUP] 3 [/SUP], Autumn Kieber-Emmons[SUP] 4 [/SUP], Mark Ebell[SUP] 5 [/SUP], Daniel T Leung[SUP] 1 6 [/SUP], Bert K Lopansri[SUP] 1 3 [/SUP]


Affiliations
Abstract

Background: Accurately predicting hospitalization risk in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive outpatients is critical for triage and resource planning. We developed and externally validated a clinical prediction model for 30-day COVID-19 hospitalization using data from symptomatic adults who tested positive in the outpatient setting. The derivation cohort included 22 859 patients from 185 outpatient clinics in a large Utah health care network between December 2021 and March 2023, during Omicron variant predominance. Among these patients, 281 (1.2%) were hospitalized for COVID-19 within 30 days.
Methods: We fit random forest and multivariable logistic regression models incorporating clinical variables (vital signs, comorbidities, and vaccination status), social determinants of health, seasonality, and air quality indices. We externally validated our model using data from 10 670 patients in a Pennsylvania healthcare network who tested positive between October 2021 and November 2022, among whom 166 (1.6%) were hospitalized.
Results: In cross-validation, a random forest model including only clinical predictors performed similarly to an expanded model that also included social, environmental, and seasonal predictors (area under the receiver operator characteristic curve [AUC]: 0.83, 95% CI: 0.77-0.88 for both). A parsimonious logistic regression model with only 3 clinical predictors (respiratory rate, age, and pulse oximetry) achieved an AUC of 0.79 (95% CI: .72-.86) on internal validation and an AUC of 0.88 (95% CI: .85-.90) on external validation. Calibration was robust, and decision curve analysis demonstrated clinical utility at low-risk thresholds.
Conclusions: We conclude that a parsimonious 3-predictor model can effectively stratify hospitalization risk in SARS-CoV-2 positive outpatients, offering a practical tool to support clinical decision-making and optimize resource allocation during current and future COVID-19 surges.

Keywords: COVID-19; prediction model; respiratory infections; triage.

 
Back
Top